Concord Medical Files Annual Report on Form 20-F for Fiscal 2024

Rhea-AI Summary

Concord Medical Services Holdings (NYSE: CCM), a Chinese healthcare provider specializing in cancer treatment, research, education and prevention, has announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission.

The electronic copy of the Annual Report is accessible on Concord Medical's investor relations website and the SEC's website. Shareholders can request free hard copies of the audited financial statements through the company's investor relations portal.

BEIJING, April 25, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov. Shareholders may receive a hard copy of the audited financial statements free of charge upon request. Requests should be submitted to http://ir.ccm.cn. 

About Concord Medical

Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across China. For more information, please see http://ir.ccm.cn. 

Forward-Looking Statements

This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company's control and based upon premises with respect to future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

View original content:https://www.prnewswire.com/news-releases/concord-medical-files-annual-report-on-form-20-f-for-fiscal-2024-302438385.html

SOURCE Concord Medical Services Holdings Limited

FAQ

Where can investors access Concord Medical's (CCM) 2024 annual report?

Investors can access CCM's 2024 annual report on Form 20-F through the company's investor relations website at ir.ccm.cn or the SEC's website at www.sec.gov.

How can shareholders obtain a hard copy of CCM's 2024 financial statements?

Shareholders can request a free hard copy of the audited financial statements by submitting a request through Concord Medical's investor relations website at ir.ccm.cn.

What is Concord Medical's (CCM) primary business focus?

Concord Medical is a healthcare provider specialized in cancer treatment, research, education and prevention in China.

When did Concord Medical (CCM) file its 2024 Form 20-F?

Concord Medical filed its annual report on Form 20-F for fiscal year 2024 on April 25, 2025.